Annual CFO
-$192.23 M
-$186.38 M-3184.32%
December 31, 2023
Summary
- As of February 12, 2025, IGMS annual cash flow from operations is -$192.23 million, with the most recent change of -$186.38 million (-3184.32%) on December 31, 2023.
- During the last 3 years, IGMS annual CFO has fallen by -$124.35 million (-183.19%).
- IGMS annual CFO is now -3184.32% below its all-time high of -$5.85 million, reached on December 31, 2022.
Performance
IGMS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$38.38 M
-$1.01 M-2.71%
September 30, 2024
Summary
- As of February 12, 2025, IGMS quarterly cash flow from operations is -$38.38 million, with the most recent change of -$1.01 million (-2.71%) on September 30, 2024.
- Over the past year, IGMS quarterly CFO has increased by +$1.74 million (+4.33%).
- IGMS quarterly CFO is now -134.49% below its all-time high of $111.31 million, reached on June 30, 2022.
Performance
IGMS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$166.18 M
+$1.74 M+1.03%
September 30, 2024
Summary
- As of February 12, 2025, IGMS TTM cash flow from operations is -$166.18 million, with the most recent change of +$1.74 million (+1.03%) on September 30, 2024.
- Over the past year, IGMS TTM CFO has increased by +$15.90 million (+8.73%).
- IGMS TTM CFO is now -6227.73% below its all-time high of $2.71 million, reached on June 30, 2022.
Performance
IGMS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
IGMS Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3184.3% | +4.3% | +8.7% |
| 3 y3 years | -183.2% | -1.4% | -2739.3% |
| 5 y5 years | -859.0% | -1.4% | -2739.3% |
IGMS Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3184.3% | at low | -134.5% | +27.7% | -6227.7% | +13.6% |
| 5 y | 5-year | -3184.3% | at low | -134.5% | +27.7% | -6227.7% | +13.6% |
| alltime | all time | -3184.3% | at low | -134.5% | +27.7% | -6227.7% | +13.6% |
IGM Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$38.38 M(+2.7%) | -$166.18 M(-1.0%) |
| Jun 2024 | - | -$37.37 M(-11.9%) | -$167.92 M(-8.6%) |
| Mar 2024 | - | -$42.42 M(-11.6%) | -$183.65 M(-4.5%) |
| Dec 2023 | -$192.23 M(+3184.3%) | -$48.01 M(+19.7%) | -$192.23 M(+5.6%) |
| Sep 2023 | - | -$40.12 M(-24.4%) | -$182.08 M(-0.2%) |
| Jun 2023 | - | -$53.10 M(+4.1%) | -$182.37 M(+915.4%) |
| Mar 2023 | - | -$51.00 M(+34.7%) | -$17.96 M(+206.9%) |
| Dec 2022 | -$5.85 M(-95.3%) | -$37.86 M(-6.3%) | -$5.85 M(+77.6%) |
| Sep 2022 | - | -$40.41 M(-136.3%) | -$3.29 M(-221.5%) |
| Jun 2022 | - | $111.31 M(-386.2%) | $2.71 M(-102.0%) |
| Mar 2022 | - | -$38.89 M(+10.2%) | -$135.61 M(+8.5%) |
| Dec 2021 | -$124.98 M | -$35.30 M(+2.6%) | -$124.98 M(+10.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$34.41 M(+27.4%) | -$113.02 M(+20.6%) |
| Jun 2021 | - | -$27.01 M(-4.4%) | -$93.69 M(+17.5%) |
| Mar 2021 | - | -$28.26 M(+21.1%) | -$79.76 M(+17.5%) |
| Dec 2020 | -$67.88 M(+50.5%) | -$23.34 M(+54.8%) | -$67.88 M(+19.9%) |
| Sep 2020 | - | -$15.07 M(+15.3%) | -$56.61 M(-0.5%) |
| Jun 2020 | - | -$13.08 M(-20.2%) | -$56.91 M(+7.1%) |
| Mar 2020 | - | -$16.39 M(+35.8%) | -$53.16 M(+17.8%) |
| Dec 2019 | -$45.12 M(+125.1%) | -$12.07 M(-21.5%) | -$45.12 M(+36.5%) |
| Sep 2019 | - | -$15.38 M(+65.0%) | -$33.05 M(+87.0%) |
| Jun 2019 | - | -$9.32 M(+11.7%) | -$17.67 M(+111.7%) |
| Mar 2019 | - | -$8.35 M | -$8.35 M |
| Dec 2018 | -$20.04 M(+93.5%) | - | - |
| Dec 2017 | -$10.36 M | - | - |
FAQ
- What is IGM Biosciences annual cash flow from operations?
- What is the all time high annual CFO for IGM Biosciences?
- What is IGM Biosciences annual CFO year-on-year change?
- What is IGM Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for IGM Biosciences?
- What is IGM Biosciences quarterly CFO year-on-year change?
- What is IGM Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for IGM Biosciences?
- What is IGM Biosciences TTM CFO year-on-year change?
What is IGM Biosciences annual cash flow from operations?
The current annual CFO of IGMS is -$192.23 M
What is the all time high annual CFO for IGM Biosciences?
IGM Biosciences all-time high annual cash flow from operations is -$5.85 M
What is IGM Biosciences annual CFO year-on-year change?
Over the past year, IGMS annual cash flow from operations has changed by -$186.38 M (-3184.32%)
What is IGM Biosciences quarterly cash flow from operations?
The current quarterly CFO of IGMS is -$38.38 M
What is the all time high quarterly CFO for IGM Biosciences?
IGM Biosciences all-time high quarterly cash flow from operations is $111.31 M
What is IGM Biosciences quarterly CFO year-on-year change?
Over the past year, IGMS quarterly cash flow from operations has changed by +$1.74 M (+4.33%)
What is IGM Biosciences TTM cash flow from operations?
The current TTM CFO of IGMS is -$166.18 M
What is the all time high TTM CFO for IGM Biosciences?
IGM Biosciences all-time high TTM cash flow from operations is $2.71 M
What is IGM Biosciences TTM CFO year-on-year change?
Over the past year, IGMS TTM cash flow from operations has changed by +$15.90 M (+8.73%)